Skip to contents

  1. Pichler, Hans [Author] ; Feiks, Erich [Contributor]; Finke, Franz [Contributor]; Kasper, Franz [Contributor]; Krause, Erich R. [Contributor]; Kutschera, Wolfgang [Contributor]; Burkert, Alois [Contributor]; Donth, Hans H. [Contributor]; Donth, Reinhard [Contributor]; Donth, Marie [Contributor]; Erlebach, Stefan [Contributor]; Farker, Rudolf [Contributor]; Feiks, Heinrich [Contributor]; Feistauer, Josef [Contributor]; Gira, Georg [Contributor]; Häusermann-Hollmann, Klara [Contributor]; Heinzel, Walter [Contributor]; Hollmann-Kirscher, Anni [Contributor]; Hübner, Hermann [Contributor]; Krause, Josef [Contributor]; Langhammer, Josef [Contributor]; Lauer, Otta [Contributor]; Mai, Oskar [Contributor]; Preis, Franz [Contributor]; Renner, Georg [Contributor]; [...]

    Stará vlast Rokytnice v Krkonoších - [1. vydání]

    Books
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Rokytnice nad Jizerou: město Rokytnice nad Jizerou, 2021

  2. Adkins, Irena; Antosova, Zuzana; Danova, Klara; Hladikova, Kamila; Augustynkova, Katerina; Sajnerova, Katerina; Podzimkova, Nada; Marasek, Pavel; de Martynoff, Guy; Bechard, David; Moebius, Ulrich; Spisek, Radek

    Abstract 3510: SOT201 is a novel targeted IL-15Rbg agonist to alleviate PD-1-mediated immune cell suppression and potentiate anti-tumor efficacy

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Association for Cancer Research (AACR), 2022

    Published in: Cancer Research, 82 (2022) 12_Supplement, Seite 3510-3510

  3. Ulrich Moebius; Radek Špíšek; David Béchard; Zuzana Antosova; Nada Podzimkova; Irena Adkins; Klara Danova; Lenka Palova Jelinkova; Katerina Behalova; Petr Danek; Matej Fabisik; Kamila Hladikova; Nataliia Kalynovska; Lucie Kosinova; Pavel Marasek; Vladyslav Mazhara; Jan Praslicka; Katerina Sajnerova; Milada Sirova; Marek Kovar; Martin Steegmaier

    1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    2023

    Published in: Journal for ImmunoTherapy of Cancer, 11 (2023)